Abstract & Overview
Background: Metabolic syndrome (MetS) is a complex of metabolic disorder that results into dyslipidemia, obesity, hypertension, hyperglycemia, and insulin resistance,which increases cardiometabolic risk in women as they transit through menopause. Aim: This study evaluated anthropometric and biochemical markers associated with MetS among premenopausal, perimenopausal and postmenopausal women so as to increase knowledge on changes associated with menopausal transition as it affects women’s health. Method: The design was a cross-sectional multistage/cluster sampling technique, with 669 women between 18–60 years, randomly selected from rural, suburban, and urban zones in Kaduna State, Nigeria. Clinical evaluation, including anthropometric measurements and biochemical analyses, were carried out and statistical tests to compare the means of various parameters between the menopausal stages were conducted. Results: A significant increase (p = 0.001) in the weight, BMI, waist circumference, systolic and diastolic blood pressures, fasting blood sugar, triglyceride and total cholesterol concentrations during perimenopausal and postmenopausal stages were observed as compared to premenopausal stage. The artherogenic index of plasma (AIP) and visceral adiposity index (VAI) were also higher in perimenopausal and postmenopausal women, implying the increased cardiovascular disease risk as women advance through menopause. Conclusion: The present study shows that the menopausal stage is accompanied with higher MetS-related anthropometric and biochemical indicators, suggesting that specific prevention strategies for cardiovascular disease should be a concern for women as they transit through menopause.